Skip to content

QuantumIQ

A small, early-stage quantum-readiness vendor acquired via reverse-merger-style share swap by an AI drug-discovery company diversifying into cybersecurity; the deal structure (public micro-cap acquirer, milestone escrow shares) suggests an early, unproven business rather than a scaled security vendor.

+ Add to Compare
35/100Emerging / Unranked

Innovation Matrix Assessment

Innovation Velocity 3/10

No independently verifiable product-shipping milestones were found beyond the general description of an encryption-readiness assessment tool.

Operational Value 2/10

No named customers or production deployments were disclosed in any acquisition coverage found.

Market Momentum 4/10

Acquired via an all-share deal by publicly listed Redwood AI Corp. (CSE: AIRX) in August 2026, though the milestone-escrow structure suggests unproven traction.

Category Disruption 4/10

Post-quantum cryptography readiness is an emerging, still-forming category with growing government and enterprise attention.

Real-World Efficacy 2/10

No checkable adoption evidence (named customers, usage data) was found; the acquirer itself is not a cybersecurity company, limiting third-party validation.

Enduring Relevance 6/10

Quantum-safe encryption preparation is a rising long-term priority as quantum computing advances threaten current cryptographic standards.

Why CISOs Should Care

Quantum.IQ builds software that helps organizations assess and prepare their encryption systems for future quantum-enabled decryption threats, giving security leaders an early tool for post-quantum cryptography readiness planning.

What Makes It Different

Quantum.IQ is a quantum-resistant cybersecurity platform that was absorbed into Redwood AI Corp., a publicly listed (CSE: AIRX) AI-for-chemistry company, via an all-share deal issuing up to roughly 14 million Redwood shares to former Quantum.IQ shareholders, including performance-milestone escrow tranches.

The Matrix Verdict

35/100 — EMERGING / UNRANKED

A small, early-stage quantum-readiness vendor acquired via reverse-merger-style share swap by an AI drug-discovery company diversifying into cybersecurity; the deal structure (public micro-cap acquirer, milestone escrow shares) suggests an early, unproven business rather than a scaled security vendor.

Editorial Note: Claims vs. Verified Findings

No customer names, revenue, or independently verifiable deployment evidence were found in deal coverage; the acquisition appears to be financial/strategic diversification by the acquirer rather than a signal of Quantum.IQ's own commercial traction.

Sources